[Sponsored] Addressing the evolving needs of pharma for CDx development
[Sponsored] Addressing the evolving needs of pharma for CDx development
Paul Beresford and Lou Welebob of Agilent Technologies discuss how partnerships are vital in addressing the evolving nee... Read more
19 Dec 2023
•
19mins
'The Top Line': A closer look at the Fierce 50
'The Top Line': A closer look at the Fierce 50
Earlier this year, Fierce Healthcare, Fierce Pharma and Fierce Biotech recognized 50 individuals and companies that are ... Read more
15 Dec 2023
•
30mins
Similar Podcasts
'The Top Line': Turning down the toxicity of nature’s most powerful antifungal
'The Top Line': Turning down the toxicity of nature’s most powerful antifungal
The antifungal agent Amphotericin B is highly effective against a wide range of deadly fungi and resistance is rare, eve... Read more
8 Dec 2023
•
27mins
'The Top Line': Fiercest Women in Life Sciences, meet the Fierce 50
'The Top Line': Fiercest Women in Life Sciences, meet the Fierce 50
In this episode of "The Top Line," we're highlighting the remarkable women featured in our annual Fiercest Women in Life... Read more
1 Dec 2023
•
11mins
'The Top Line': Exploring Alzheimer’s breakthroughs, Leqembi's potential and what comes next
'The Top Line': Exploring Alzheimer’s breakthroughs, Leqembi's potential and what comes next
This episode of "The Top Line" is dedicated to Alzheimer’s disease, exploring the latest treatments and what lies ahead.... Read more
17 Nov 2023
•
18mins
'The Top Line': A look at psychedelics and the next frontier of mental healthcare
'The Top Line': A look at psychedelics and the next frontier of mental healthcare
In this episode of “The Top Line,” we explore the next potential wave of mental health therapy: psychedelics. Fierce Bi... Read more
10 Nov 2023
•
17mins
'The Top Line': Exploring the promise of earlier Alzheimer's treatment
'The Top Line': Exploring the promise of earlier Alzheimer's treatment
While the new Alzheimer’s disease medicine Leqembi has generated lots of buzz since its debut this year, one research te... Read more
3 Nov 2023
•
13mins
'The Top Line': A look at the FDA's Aduhelm approval and the potential for regulatory bias
'The Top Line': A look at the FDA's Aduhelm approval and the potential for regulatory bias
In this episode of “The Top Line,” we delve into the FDA's controversial approval of Aduhelm, a drug for Alzheimer's dis... Read more
27 Oct 2023
•
15mins
'The Top Line': Leqembi's full approval and the future of Alzheimer's treatment
'The Top Line': Leqembi's full approval and the future of Alzheimer's treatment
In this episode of "The Top Line," Fierce's Fraiser Kansteiner engages in a conversation with Alexander Scott, senior vi... Read more
20 Oct 2023
•
16mins
'The Top Line': Unraveling Alzheimer's disease treatments and a look ahead
'The Top Line': Unraveling Alzheimer's disease treatments and a look ahead
In this episode of "The Top Line," Fierce Biotech's Annalee Armstrong engages in a conversation with Howard Fillit, M.D.... Read more
13 Oct 2023
•
28mins